Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

NB: AS OF JANUARY 1, 2023 THIS JOURNAL IS PUBLISHED WITH ELSEVIER: https://www.sciencedirect.com/journal/mucosal-immunology

Volume 14 Issue 5, September 2021

This cover image shows 3D volume renderings of 18F-FDG PET/CT scans of a Mycobacterium tuberculosis infected rhesus macaques treated with PBS (above) or the MAIT cell TCR agonist 5-OP-RU (below) from prior to infection, 5- and 10-weeks post-infection (left to right). Image courtesy of Dr. Shunsuke Sakai and Dr. Daniel L. Barber, NIAID/NIH. please see the article in this issue, pages 1055–1066.

Volume 14 Issue 5

Comment

  • The interaction between fungal pathogens and host epithelial barriers remains largely unexplored. In a recent issue of Nature Microbiology, Pekmezovic et al. (Nat. Microbiol. 2021) provides evidence for the pivotal role of mitochondria-associated type I interferon signalling in the pathophysiology of vulvovaginal candidiasis.

    • Nicolas Papon
    • Julian R. Naglik
    Comment

    Advertisement

Top of page ⤴

Review Article

Top of page ⤴

Article

Top of page ⤴

Correspondence

Top of page ⤴

Correction

Top of page ⤴

Search

Advanced search

Quick links